Subscribe
F011 Will VR decrease drug expenditure? (Walter Greenleaf, Stanford)

Faces of Digital Health

F011 Will VR decrease drug expenditure? (Walter Greenleaf, Stanford)

According to dr. Walter Greenleaf, behavioral neuroscientist and a medical technology developer working at Stanford University, interactive virtual environments significantly reduce pain from as much as 44% during the most…
May 15, 2018

F011 Will VR decrease drug expenditure? (Walter Greenleaf, Stanford)

According to dr. Walter Greenleaf, behavioral neuroscientist and a medical technology developer working at Stanford University, interactive virtual environments significantly reduce pain from as much as 44% during the most painful procedures (ex: burn wound treatment), diverts patient attention away from perceiving and feeling pain, decreases pain-related brain-activity, reduces need for anesthesia, opioid medication.
With the decrease in price, VR is getting mainstream. The technology giants such as Facebook and Samsung are making huge investments, according to Statista, 12.4 million units will be shipped worldwide in 2018, more than 5 times as much in 4 years in 2022.
Listen to a conversation with dr. Walter Greenleaf, Medical Director for AppliedVR at Stanford University. He is considered a leading authority in the medical VR field with over three decades of research and development experience in the field of digital medicine and medical virtual reality technology.

Listen on your favorite player

New to Podcasts? It's easy to get started!

You may also like

The Latest Health Podcasts. Delivered to Your Inbox.

Proudly supported by:

Get HealthHealthXL